Cite
HARVARD Citation
Forschner, A. et al. (2019). Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study. Journal for immunotherapy of cancer. 7 (1), p. . [Online].